US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avalo Therapeutics Inc

16.25

+0.49003.11%

Post-market: 16.250.00000.00%18:03 EST

Volume:315.61K

Turnover:5.17M

Market Cap:300.83M

PE:-1.86

High:17.12

Open:15.94

Low:15.65

Close:15.76

52wk High:20.72

52wk Low:3.39

Shares:18.51M

Float Shares:11.60M

Volume Ratio:0.83

T/O Rate:2.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.7421

EPS(LYR):-7.9367

ROE:-174.79%

ROA:-37.18%

PB:3.29

PE(LYR):-2.05

Loading ...

Overview Company News Filings

Avalo Therapeutics Files $750 Million Mixed Shelf

MT Newswires Live

BRIEF-Avalo Therapeutics Files For Mixed Shelf Of Up To $750 Million - SEC Filing

Avalo Therapeutics files $750M mixed securities shelf

Avalo Therapeutics Inc Files for Mixed Shelf of up to $750 Mln - SEC Filing

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar

Avalo Therapeutics Unveils Pipeline Progress Highlighting Lead IL-1β Antibody for Hidradenitis Suppurativa

Will Avalo Therapeutics (NASDAQ:AVTX) Spend Its Cash Wisely?

Simply Wall St.

Avalo Q3 net loss misses estimates, LOTUS trial enrollment complete

Avalo Therapeutics reports third quarter revenue of zero dollars

Avalo Therapeutics: Cash & Short-Term Investments of About $112 Mln as of Sept 30, Expected to Provide Runway Into 2028

THOMSON REUTERS

Avalo Therapeutics Q3 Operating Expenses USD 19.198 Million

THOMSON REUTERS

Press Release: Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

Avalo Therapeutics Inc expected to post a loss of $1.66 a share - Earnings Preview

Avalo Therapeutics to Participate in Piper Sandler Annual Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX) and Anavex Life Sciences (AVXL)

BRIEF-Avalo Therapeutics Announces Completion Of Enrollment In Phase 2 LOTUS Trial Of AVTX-009 For The Treatment Of Hidradenitis Suppurativa

Avalo Therapeutics - Lotus Trial Enrolls 250 Patients, Topline Data From Trial Is Expected in Mid-2026.

THOMSON REUTERS

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 Lotus Trial of Avtx-009 for the Treatment of Hidradenitis Suppurativa

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Wuxi Biologics (Cayman) (OtherWXIBF) and Avalo Therapeutics (AVTX)

Avalo Therapeutics Inc publishes presentation on advancing IL1β therapies for hidradenitis suppurativa

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVTX\",,,,,undefined,":{"symbol":"AVTX","market":"US","secType":"STK","nameCN":"Avalo Therapeutics Inc","latestPrice":16.25,"timestamp":1769115600000,"preClose":15.76,"halted":0,"volume":315614,"hourTrading":{"tag":"盘后","latestPrice":16.25,"preClose":16.25,"latestTime":"18:03 EST","volume":25331,"amount":411628.43,"timestamp":1769123003886,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.031091370558375648,"floatShares":11601900,"shares":18512800,"eps":-8.742119,"marketStatus":"Closed","change":0.49,"latestTime":"01-22 16:00:00 EST","open":15.94,"high":17.115,"low":15.645,"amount":5166361.944588,"amplitude":0.093274,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.742119,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1769158800000},"marketStatusCode":5,"adr":0,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":15.76,"postHourTrading":{"tag":"盘后","latestPrice":16.25,"preClose":16.25,"latestTime":"18:03 EST","volume":25331,"amount":411628.43,"timestamp":1769123003886,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.827519,"impliedVol":0.8169,"impliedVolPercentile":0.4508},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVTX\",,,,,undefined,":{"symbol":"AVTX","floatShares":11601900,"roa":"-37.18%","roe":"-174.79%","lyrEps":-7.936696,"volumeRatio":0.827519,"shares":18512800,"dividePrice":0,"high":17.115,"amplitude":0.093274,"preClose":15.76,"low":15.645,"week52Low":3.39,"pbRate":"3.29","psRate":"1566.84","week52High":20.7199,"institutionHeld":0,"latestPrice":16.25,"eps":-8.742119,"divideRate":0,"volume":315614,"delay":0,"ttmEps":-8.742119,"open":15.94,"prevYearClose":18.16,"prevWeekClose":15.06,"prevMonthClose":18.16,"prevQuarterClose":18.16,"fiveDayClose":16.19,"twentyDayClose":19.17,"sixtyDayClose":17.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"AVTX","fiscalQuarterEnding":"2025/09","expectedEps":-1.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-2.19},{"market":"US","date":"2025-08-07","symbol":"AVTX","fiscalQuarterEnding":"2025/06","expectedEps":-1.43,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-1.92},{"market":"US","date":"2025-05-12","symbol":"AVTX","fiscalQuarterEnding":"2025/03","expectedEps":-1.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.25},{"date":"2025-03-20","symbol":"AVTX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742457600000,"name":null,"time":"Pre-Market","dateTimestamp":1742443200000,"actualEps":null},{"market":"US","date":"2024-11-07","symbol":"AVTX","fiscalQuarterEnding":"2024/09","expectedEps":-1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-2.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1766034000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVTX","date":"2026-01-21","current":-1.858817,"percent":0.333867,"low":-17.724274,"twenty":-3.659794,"median":-1.094689,"eighty":-0.302346,"high":1.330244,"avg":-2.563393,"sd":3.446688,"marketCap":273988803},"quantilePoints":[{"date":"2021-01-22","current":-12.437332,"twenty":-29.301295,"median":-12.508024,"eighty":10.9659,"marketCap":575051829},{"date":"2021-01-29","current":-11.193599,"twenty":-29.257893,"median":-12.397456,"eighty":10.930525,"marketCap":517546654},{"date":"2021-02-05","current":-12.224121,"twenty":-29.204541,"median":-12.275125,"eighty":10.877747,"marketCap":565193801},{"date":"2021-02-12","current":-14.071953,"twenty":-29.193248,"median":-12.397456,"eighty":10.865441,"marketCap":650630081},{"date":"2021-02-19","current":-15.422292,"twenty":-29.187522,"median":-12.437332,"eighty":10.849579,"marketCap":713064270},{"date":"2021-02-26","current":-11.975375,"twenty":-29.155551,"median":-12.629232,"eighty":10.759695,"marketCap":553692769},{"date":"2021-03-05","current":-11.015923,"twenty":-29.107122,"median":-12.578715,"eighty":10.69096,"marketCap":509331617},{"date":"2021-03-12","current":-8.783753,"twenty":-29.081023,"median":-12.41231,"eighty":10.632799,"marketCap":557768296},{"date":"2021-03-19","current":-8.317359,"twenty":-29.076805,"median":-12.32613,"eighty":10.569351,"marketCap":528152278},{"date":"2021-03-26","current":-7.721411,"twenty":-29.076805,"median":-12.199351,"eighty":10.468892,"marketCap":490309592},{"date":"2021-04-01","current":-7.902786,"twenty":-29.064495,"median":-12.117515,"eighty":10.414053,"marketCap":501826927},{"date":"2021-04-09","current":-4.223444,"twenty":-29.037158,"median":-11.975375,"eighty":10.392345,"marketCap":268188685},{"date":"2021-04-16","current":-3.772542,"twenty":-28.978675,"median":-11.782329,"eighty":10.363783,"marketCap":239556445},{"date":"2021-04-23","current":-3.832663,"twenty":-28.908286,"median":-11.603531,"eighty":10.344812,"marketCap":243374076},{"date":"2021-04-30","current":-5.033553,"twenty":-28.873662,"median":-11.477881,"eighty":10.314495,"marketCap":319630639},{"date":"2021-05-07","current":-4.360276,"twenty":-28.815777,"median":-11.358387,"eighty":10.299698,"marketCap":276877496},{"date":"2021-05-14","current":-3.065095,"twenty":-28.797982,"median":-11.273332,"eighty":10.273261,"marketCap":223945029},{"date":"2021-05-21","current":-3.664182,"twenty":-28.797982,"median":-11.193599,"eighty":10.215101,"marketCap":267716103},{"date":"2021-05-28","current":-3.678114,"twenty":-28.764102,"median":-11.133671,"eighty":10.133501,"marketCap":268734035},{"date":"2021-06-04","current":-4.040352,"twenty":-28.694819,"median":-11.033312,"eighty":10.096895,"marketCap":295200264},{"date":"2021-06-11","current":-4.820558,"twenty":-28.615925,"median":-10.989686,"eighty":10.040821,"marketCap":352204457},{"date":"2021-06-18","current":-5.113136,"twenty":-28.574375,"median":-10.898739,"eighty":9.961705,"marketCap":373581029},{"date":"2021-06-25","current":-4.959881,"twenty":-28.467475,"median":-10.767176,"eighty":9.920591,"marketCap":362383782},{"date":"2021-07-02","current":-4.611575,"twenty":-28.363521,"median":-10.663809,"eighty":9.823839,"marketCap":336935475},{"date":"2021-07-09","current":-4.541913,"twenty":-28.289783,"median":-10.561107,"eighty":9.781541,"marketCap":331845818},{"date":"2021-07-16","current":-3.984623,"twenty":-28.233316,"median":-10.535567,"eighty":9.496615,"marketCap":291128538},{"date":"2021-07-23","current":-3.970691,"twenty":-28.176849,"median":-10.47995,"eighty":9.48958,"marketCap":290110606},{"date":"2021-07-30","current":-3.705978,"twenty":-28.034582,"median":-10.447359,"eighty":9.473166,"marketCap":270769898},{"date":"2021-08-06","current":-3.521339,"twenty":-28.007449,"median":-10.388568,"eighty":9.437865,"marketCap":270745213},{"date":"2021-08-13","current":-3.583774,"twenty":-27.993401,"median":-10.353919,"eighty":9.26213,"marketCap":275545658},{"date":"2021-08-20","current":-3.458904,"twenty":-27.950982,"median":-10.321084,"eighty":9.226372,"marketCap":265944768},{"date":"2021-08-27","current":-3.746106,"twenty":-27.912102,"median":-10.296091,"eighty":9.168337,"marketCap":288026824},{"date":"2021-09-03","current":-3.77108,"twenty":-27.794004,"median":-10.152466,"eighty":9.097991,"marketCap":289947002},{"date":"2021-09-10","current":-3.371495,"twenty":-27.754166,"median":-10.071375,"eighty":9.052651,"marketCap":259224136},{"date":"2021-09-17","current":-3.584646,"twenty":-27.741285,"median":-10.010089,"eighty":9.041316,"marketCap":275612704},{"date":"2021-09-24","current":-3.40118,"twenty":-27.720368,"median":-9.948802,"eighty":8.842793,"marketCap":261506538},{"date":"2021-10-01","current":-3.175376,"twenty":-27.692747,"median":-9.808976,"eighty":8.455504,"marketCap":244145106},{"date":"2021-10-08","current":-3.076586,"twenty":-27.644344,"median":-9.788996,"eighty":8.277296,"marketCap":236549483},{"date":"2021-10-15","current":-3.203601,"twenty":-27.548134,"median":-9.683229,"eighty":8.160054,"marketCap":246315284},{"date":"2021-10-22","current":-3.076586,"twenty":-27.455144,"median":-9.574924,"eighty":8.136606,"marketCap":236549483},{"date":"2021-10-29","current":-3.302391,"twenty":-27.380571,"median":-9.493905,"eighty":8.117847,"marketCap":253910916},{"date":"2021-11-05","current":-3.344729,"twenty":-27.036834,"median":-9.429309,"eighty":7.981846,"marketCap":257166182},{"date":"2021-11-12","current":-3.182359,"twenty":-26.858723,"median":-9.356369,"eighty":7.9115,"marketCap":257207809},{"date":"2021-11-19","current":-3.015598,"twenty":-26.737364,"median":-9.33594,"eighty":7.864604,"marketCap":243729676},{"date":"2021-11-26","current":-2.904424,"twenty":-26.595155,"median":-9.284868,"eighty":7.827086,"marketCap":234744253},{"date":"2021-12-03","current":-2.501418,"twenty":-26.516587,"median":-9.233796,"eighty":7.780189,"marketCap":202172078},{"date":"2021-12-10","current":-2.570901,"twenty":-26.516587,"median":-9.17251,"eighty":7.761431,"marketCap":207787967},{"date":"2021-12-17","current":-2.418037,"twenty":-26.514174,"median":-9.111224,"eighty":7.705155,"marketCap":195433012},{"date":"2021-12-23","current":-2.584798,"twenty":-26.455248,"median":-8.941178,"eighty":7.648878,"marketCap":208911145},{"date":"2021-12-31","current":-2.36245,"twenty":-26.367673,"median":-8.941178,"eighty":7.583222,"marketCap":190940300},{"date":"2022-01-07","current":-1.445263,"twenty":-26.306356,"median":-8.876151,"eighty":7.517567,"marketCap":116810528},{"date":"2022-01-14","current":-1.389398,"twenty":-26.159064,"median":-8.843637,"eighty":7.494119,"marketCap":112295353},{"date":"2022-01-21","current":-1.221109,"twenty":-26.060869,"median":-8.802891,"eighty":7.475688,"marketCap":98693670},{"date":"2022-01-28","current":-1.282393,"twenty":-26.01256,"median":-8.783753,"eighty":7.439155,"marketCap":103646884},{"date":"2022-02-04","current":-1.247791,"twenty":-25.975647,"median":-8.746097,"eighty":7.3206,"marketCap":100850172},{"date":"2022-02-11","current":-1.220414,"twenty":-25.943036,"median":-8.7243,"eighty":7.128323,"marketCap":98637511},{"date":"2022-02-18","current":-1.147317,"twenty":-25.816165,"median":-8.667635,"eighty":7.02515,"marketCap":92729587},{"date":"2022-02-25","current":-1.090896,"twenty":-25.780016,"median":-8.651378,"eighty":6.987633,"marketCap":88169485},{"date":"2022-03-04","current":-0.949265,"twenty":-25.776105,"median":-8.602377,"eighty":6.893839,"marketCap":80095158},{"date":"2022-03-11","current":-0.908893,"twenty":-25.748784,"median":-8.58353,"eighty":6.518664,"marketCap":76688774},{"date":"2022-03-18","current":-0.958088,"twenty":-25.659547,"median":-8.58353,"eighty":6.42487,"marketCap":80839599},{"date":"2022-03-25","current":-0.844058,"twenty":-25.530618,"median":-8.531932,"eighty":6.331076,"marketCap":71218258},{"date":"2022-04-01","current":-1.164624,"twenty":-25.409984,"median":-8.498361,"eighty":6.237283,"marketCap":98266306},{"date":"2022-04-08","current":-0.872131,"twenty":-25.285131,"median":-8.402548,"eighty":6.190386,"marketCap":73586935},{"date":"2022-04-14","current":-0.801013,"twenty":-25.206576,"median":-8.378815,"eighty":6.115351,"marketCap":67586277},{"date":"2022-04-22","current":-0.754225,"twenty":-25.032859,"median":-8.29091,"eighty":5.965281,"marketCap":63638481},{"date":"2022-04-29","current":-0.549159,"twenty":-24.837204,"median":-8.177632,"eighty":5.388449,"marketCap":46335848},{"date":"2022-05-06","current":-0.492591,"twenty":-24.755633,"median":-8.063316,"eighty":0.657608,"marketCap":37312316},{"date":"2022-05-13","current":-0.372124,"twenty":-24.666505,"median":-7.915741,"eighty":-0.372064,"marketCap":28187268},{"date":"2022-05-20","current":-0.483806,"twenty":-24.607588,"median":-7.825054,"eighty":-0.39035,"marketCap":36646830},{"date":"2022-05-27","current":-0.475467,"twenty":-24.561471,"median":-7.708455,"eighty":-0.406701,"marketCap":36015183},{"date":"2022-06-03","current":-0.554686,"twenty":-24.491244,"median":-7.638859,"eighty":-0.424838,"marketCap":42015832},{"date":"2022-06-10","current":-0.685578,"twenty":-24.450476,"median":-7.543103,"eighty":-0.442111,"marketCap":51930448},{"date":"2022-06-17","current":-0.745886,"twenty":-24.423239,"median":-7.494333,"eighty":-0.451433,"marketCap":56498611},{"date":"2022-06-24","current":-0.783113,"twenty":-24.4036,"median":-7.36477,"eighty":-0.457925,"marketCap":59318465},{"date":"2022-07-01","current":-0.774327,"twenty":-24.401379,"median":-7.185455,"eighty":-0.464656,"marketCap":58652979},{"date":"2022-07-08","current":-0.643216,"twenty":-24.401379,"median":-6.697755,"eighty":-0.468677,"marketCap":48721650},{"date":"2022-07-15","current":-0.571195,"twenty":-24.39982,"median":-5.099203,"eighty":-0.475675,"marketCap":43266330},{"date":"2022-07-22","current":-0.561261,"twenty":-24.385324,"median":-4.973813,"eighty":-0.476509,"marketCap":42513872},{"date":"2022-07-29","current":-0.447022,"twenty":-24.323558,"median":-4.959881,"eighty":-0.468677,"marketCap":33860606},{"date":"2022-08-05","current":-0.522429,"twenty":-24.18902,"median":-4.932016,"eighty":-0.463367,"marketCap":37421067},{"date":"2022-08-12","current":-0.759658,"twenty":-24.105753,"median":-4.911118,"eighty":-0.464921,"marketCap":54413526},{"date":"2022-08-19","current":-0.622972,"twenty":-24.081832,"median":-4.876287,"eighty":-0.468677,"marketCap":44622857},{"date":"2022-08-26","current":-0.628229,"twenty":-24.061348,"median":-4.771795,"eighty":-0.475675,"marketCap":44999421},{"date":"2022-09-02","current":-0.630858,"twenty":-24.041706,"median":-4.639439,"eighty":-0.476509,"marketCap":45187704},{"date":"2022-09-09","current":-0.641372,"twenty":-23.963138,"median":-4.58371,"eighty":-0.476509,"marketCap":45940832},{"date":"2022-09-16","current":-0.5428,"twenty":-23.963138,"median":-4.554975,"eighty":-0.476658,"marketCap":38880253},{"date":"2022-09-23","current":-0.414,"twenty":-23.959503,"median":-4.541913,"eighty":-0.476509,"marketCap":29654430},{"date":"2022-09-30","current":-0.436343,"twenty":-23.910406,"median":-4.514049,"eighty":-0.464407,"marketCap":31254828},{"date":"2022-10-07","current":-0.541486,"twenty":-23.815824,"median":-4.488519,"eighty":-0.464407,"marketCap":38786112},{"date":"2022-10-14","current":-0.696572,"twenty":-23.812211,"median":-4.457389,"eighty":-0.466979,"marketCap":49894756},{"date":"2022-10-21","current":-0.695258,"twenty":-23.664919,"median":-4.416523,"eighty":-0.471829,"marketCap":49800615},{"date":"2022-10-28","current":-0.801715,"twenty":-23.173945,"median":-4.33293,"eighty":-0.475467,"marketCap":57426040},{"date":"2022-11-04","current":-0.891086,"twenty":-22.833728,"median":-4.249336,"eighty":-0.475772,"marketCap":63827631},{"date":"2022-11-11","current":-1.069743,"twenty":-22.686414,"median":-4.187343,"eighty":-0.476509,"marketCap":54601803},{"date":"2022-11-18","current":-0.997812,"twenty":-22.588204,"median":-4.123946,"eighty":-0.476509,"marketCap":50930302},{"date":"2022-11-25","current":-1.007034,"twenty":-22.313217,"median":-4.088173,"eighty":-0.476628,"marketCap":51401007},{"date":"2022-12-02","current":-1.051299,"twenty":-22.08466,"median":-4.062802,"eighty":-0.476658,"marketCap":53660392},{"date":"2022-12-09","current":-0.95908,"twenty":-22.02653,"median":-4.040352,"eighty":-0.477492,"marketCap":48953340},{"date":"2022-12-16","current":-1.054988,"twenty":-21.976812,"median":-3.977747,"eighty":-0.482585,"marketCap":53848674},{"date":"2022-12-23","current":-0.924036,"twenty":-21.952977,"median":-3.970691,"eighty":-0.485116,"marketCap":47164661},{"date":"2022-12-30","current":-0.929588,"twenty":-21.714139,"median":-3.922843,"eighty":-0.488839,"marketCap":47448025},{"date":"2023-01-06","current":-0.914814,"twenty":-21.714139,"median":-3.922843,"eighty":-0.516813,"marketCap":46693955},{"date":"2023-01-13","current":-0.896371,"twenty":-21.714139,"median":-3.922843,"eighty":-0.529998,"marketCap":45752545},{"date":"2023-01-20","current":-0.903748,"twenty":-21.714139,"median":-3.922843,"eighty":-0.540172,"marketCap":46129109},{"date":"2023-01-27","current":-0.737754,"twenty":-21.714139,"median":-3.922843,"eighty":-0.547404,"marketCap":37656416},{"date":"2023-02-03","current":-1.004784,"twenty":-21.714139,"median":-3.922843,"eighty":-0.561459,"marketCap":51286164},{"date":"2023-02-10","current":-0.811059,"twenty":-21.714139,"median":-3.922843,"eighty":-0.569457,"marketCap":41398086},{"date":"2023-02-17","current":-0.80331,"twenty":-21.714139,"median":-3.922843,"eighty":-0.582314,"marketCap":41002563},{"date":"2023-02-24","current":-0.741318,"twenty":-21.714139,"median":-3.922843,"eighty":-0.608473,"marketCap":37838378},{"date":"2023-03-03","current":-0.668995,"twenty":-21.714139,"median":-3.922843,"eighty":-0.62376,"marketCap":34146829},{"date":"2023-03-10","current":-0.635416,"twenty":-21.714139,"median":-3.922843,"eighty":-0.630615,"marketCap":32432895},{"date":"2023-03-17","current":-0.568258,"twenty":-21.714139,"median":-3.922843,"eighty":-0.634644,"marketCap":29005028},{"date":"2023-03-24","current":-0.467521,"twenty":-21.714139,"median":-3.922843,"eighty":-0.634644,"marketCap":23863228},{"date":"2023-03-31","current":-0.554538,"twenty":-21.635572,"median":-3.918902,"eighty":-0.633355,"marketCap":23100936},{"date":"2023-04-06","current":-0.583057,"twenty":-21.635572,"median":-3.918902,"eighty":-0.633355,"marketCap":24288984},{"date":"2023-04-14","current":-0.817547,"twenty":-21.714139,"median":-3.922843,"eighty":-0.638743,"marketCap":34057380},{"date":"2023-04-21","current":-0.939672,"twenty":-21.714139,"median":-3.922843,"eighty":-0.641176,"marketCap":39144866},{"date":"2023-04-28","current":-0.893598,"twenty":-21.714139,"median":-3.922843,"eighty":-0.649364,"marketCap":37225508},{"date":"2023-05-05","current":-0.893598,"twenty":-21.714139,"median":-3.922843,"eighty":-0.656445,"marketCap":37225508},{"date":"2023-05-12","current":-1.071689,"twenty":-21.714139,"median":-3.922843,"eighty":-0.678145,"marketCap":31681284},{"date":"2023-05-19","current":-1.469108,"twenty":-21.714139,"median":-3.922843,"eighty":-0.694732,"marketCap":43429760},{"date":"2023-05-26","current":-1.183324,"twenty":-21.714139,"median":-3.922843,"eighty":-0.697457,"marketCap":34981417},{"date":"2023-06-02","current":-1.250304,"twenty":-21.714139,"median":-3.922843,"eighty":-0.704458,"marketCap":36961498},{"date":"2023-06-09","current":-1.85313,"twenty":-21.714139,"median":-3.922843,"eighty":-0.721523,"marketCap":54782220},{"date":"2023-06-16","current":-1.681213,"twenty":-21.714139,"median":-3.922843,"eighty":-0.735975,"marketCap":49700014},{"date":"2023-06-23","current":-1.92011,"twenty":-21.792707,"median":-3.922843,"eighty":-0.742858,"marketCap":56762300},{"date":"2023-06-30","current":-0.165219,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":4884197},{"date":"2023-07-07","current":-0.157985,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":4670349},{"date":"2023-07-14","current":-0.151064,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":4465740},{"date":"2023-07-21","current":-0.14057,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":4155528},{"date":"2023-07-28","current":-0.091987,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":2719310},{"date":"2023-08-04","current":-0.105421,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":2611065},{"date":"2023-08-11","current":-0.118547,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":2936169},{"date":"2023-08-18","current":-0.119855,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":2968568},{"date":"2023-08-25","current":-0.078486,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":1943946},{"date":"2023-09-01","current":-0.081756,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":2024944},{"date":"2023-09-08","current":-0.077505,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":1919647},{"date":"2023-09-15","current":-0.545751,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":13517171},{"date":"2023-09-22","current":-0.260184,"twenty":-21.871274,"median":-3.922843,"eighty":-0.744546,"marketCap":6444232},{"date":"2023-09-29","current":-0.83974,"twenty":-21.871274,"median":-3.922843,"eighty":-0.747543,"marketCap":20798671},{"date":"2023-10-06","current":-1.23346,"twenty":-21.871274,"median":-3.922843,"eighty":-0.759451,"marketCap":30550328},{"date":"2023-10-13","current":-1.156563,"twenty":-21.871274,"median":-3.922843,"eighty":-0.769757,"marketCap":28645742},{"date":"2023-10-20","current":-0.975583,"twenty":-21.871274,"median":-3.922843,"eighty":-0.774327,"marketCap":24163231},{"date":"2023-10-27","current":-0.812468,"twenty":-21.956113,"median":-3.970691,"eighty":-0.788268,"marketCap":20123201},{"date":"2023-11-03","current":-0.794603,"twenty":-21.956113,"median":-3.970691,"eighty":-0.791233,"marketCap":19680721},{"date":"2023-11-10","current":-0.568081,"twenty":-21.956113,"median":-3.970691,"eighty":-0.800242,"marketCap":18853477},{"date":"2023-11-17","current":-0.533301,"twenty":-21.956113,"median":-3.911388,"eighty":-0.788738,"marketCap":17699182},{"date":"2023-11-24","current":-0.510114,"twenty":-21.956113,"median":-3.911388,"eighty":-0.781087,"marketCap":16929652},{"date":"2023-12-01","current":-0.405193,"twenty":-21.956113,"median":-3.911388,"eighty":-0.773522,"marketCap":13447531},{"date":"2023-12-08","current":-0.351283,"twenty":-21.952977,"median":-3.907813,"eighty":-0.768715,"marketCap":11658374},{"date":"2023-12-15","current":-0.390701,"twenty":-21.952977,"median":-3.907813,"eighty":-0.758364,"marketCap":12966575},{"date":"2023-12-22","current":-0.289837,"twenty":-21.952977,"median":-3.907813,"eighty":-0.744294,"marketCap":9619120},{"date":"2023-12-29","current":-0.285779,"twenty":-21.956113,"median":-3.875459,"eighty":-0.739892,"marketCap":9484443},{"date":"2024-01-05","current":-0.201438,"twenty":-21.959248,"median":-3.832663,"eighty":-0.735339,"marketCap":6685335},{"date":"2024-01-12","current":-0.165933,"twenty":-21.539717,"median":-3.802603,"eighty":-0.721687,"marketCap":5506985},{"date":"2024-01-19","current":-0.099028,"twenty":-20.339205,"median":-3.77108,"eighty":-0.71639,"marketCap":3286555},{"date":"2024-01-26","current":-0.099028,"twenty":-18.397357,"median":-3.746106,"eighty":-0.703145,"marketCap":3286555},{"date":"2024-02-02","current":-0.111105,"twenty":-17.610725,"median":-3.678114,"eighty":-0.696572,"marketCap":3687355},{"date":"2024-02-09","current":-0.109897,"twenty":-17.287092,"median":-3.608748,"eighty":-0.686296,"marketCap":3647275},{"date":"2024-02-16","current":-0.11497,"twenty":-17.060081,"median":-3.596261,"eighty":-0.667404,"marketCap":3815611},{"date":"2024-02-23","current":-0.10555,"twenty":-16.912588,"median":-3.521339,"eighty":-0.655929,"marketCap":3502987},{"date":"2024-03-01","current":-0.106516,"twenty":-16.765096,"median":-3.471567,"eighty":-0.646875,"marketCap":3535051},{"date":"2024-03-08","current":-0.126563,"twenty":-16.568438,"median":-3.425425,"eighty":-0.640761,"marketCap":4200378},{"date":"2024-03-15","current":-0.120766,"twenty":-16.470107,"median":-3.372955,"eighty":-0.638445,"marketCap":4007995},{"date":"2024-03-22","current":-0.111105,"twenty":-16.346034,"median":-3.352765,"eighty":-0.632043,"marketCap":3687355},{"date":"2024-03-28","current":-0.114728,"twenty":-16.224284,"median":-3.339382,"eighty":-0.626072,"marketCap":3807595},{"date":"2024-04-05","current":-0.534375,"twenty":-15.893573,"median":-3.288278,"eighty":-0.622972,"marketCap":16856319},{"date":"2024-04-12","current":-0.516344,"twenty":-15.71691,"median":-3.217714,"eighty":-0.591964,"marketCap":16287547},{"date":"2024-04-19","current":-0.393733,"twenty":-15.525068,"median":-3.189488,"eighty":-0.579334,"marketCap":12419901},{"date":"2024-04-26","current":-0.4911,"twenty":-15.372511,"median":-3.165541,"eighty":-0.572109,"marketCap":15491267},{"date":"2024-05-03","current":-0.504542,"twenty":-14.974453,"median":-3.122848,"eighty":-0.568608,"marketCap":15915260},{"date":"2024-05-10","current":-0.376685,"twenty":-14.700281,"median":-3.08789,"eighty":-0.563159,"marketCap":11882153},{"date":"2024-05-17","current":-0.069772,"twenty":-14.507008,"median":-3.056728,"eighty":-0.559476,"marketCap":9969013},{"date":"2024-05-24","current":-0.080701,"twenty":-14.246926,"median":-3.024815,"eighty":-0.554078,"marketCap":11530549},{"date":"2024-05-31","current":-0.084574,"twenty":-13.988803,"median":-2.975744,"eighty":-0.547796,"marketCap":12083809},{"date":"2024-06-07","current":-0.073898,"twenty":-13.789051,"median":-2.772404,"eighty":-0.54096,"marketCap":10558467},{"date":"2024-06-14","current":-0.079109,"twenty":-13.520986,"median":-2.591747,"eighty":-0.535614,"marketCap":11303040},{"date":"2024-06-21","current":-0.094381,"twenty":-13.284766,"median":-2.543108,"eighty":-0.53046,"marketCap":13485055},{"date":"2024-06-28","current":-0.090255,"twenty":-13.134401,"median":-2.473624,"eighty":-0.523154,"marketCap":12895601},{"date":"2024-07-05","current":-0.091124,"twenty":-13.033367,"median":-2.418037,"eighty":-0.521733,"marketCap":13019696},{"date":"2024-07-12","current":-0.088012,"twenty":-12.98285,"median":-2.32076,"eighty":-0.516714,"marketCap":12575020},{"date":"2024-07-19","current":-0.092485,"twenty":-12.932334,"median":-1.844199,"eighty":-0.510114,"marketCap":13214216},{"date":"2024-07-26","current":-0.083524,"twenty":-12.760576,"median":-1.73703,"eighty":-0.495034,"marketCap":11933860},{"date":"2024-08-02","current":-0.078169,"twenty":-12.433265,"median":-1.469108,"eighty":-0.489527,"marketCap":11168707},{"date":"2024-08-09","current":-0.0773,"twenty":-12.245442,"median":-1.384266,"eighty":-0.477761,"marketCap":11044508},{"date":"2024-08-16","current":-2.424403,"twenty":-12.010646,"median":-1.355629,"eighty":-0.476569,"marketCap":87819132},{"date":"2024-08-23","current":-2.459151,"twenty":-11.65256,"median":-1.355629,"eighty":-0.476569,"marketCap":89077840},{"date":"2024-08-30","current":-1.871093,"twenty":-11.408762,"median":-1.355629,"eighty":-0.476569,"marketCap":67776618},{"date":"2024-09-06","current":-2.020781,"twenty":-11.214921,"median":-1.355629,"eighty":-0.476569,"marketCap":73198747},{"date":"2024-09-13","current":-2.400346,"twenty":-11.081984,"median":-1.355629,"eighty":-0.476569,"marketCap":86947718},{"date":"2024-09-20","current":-2.598147,"twenty":-10.951814,"median":-1.355629,"eighty":-0.476569,"marketCap":94112675},{"date":"2024-09-27","current":-2.512611,"twenty":-10.712195,"median":-1.355629,"eighty":-0.476569,"marketCap":91014315},{"date":"2024-10-04","current":-2.610951,"twenty":-10.538968,"median":-1.355629,"eighty":-0.476569,"marketCap":94576460},{"date":"2024-10-11","current":-2.550033,"twenty":-10.454656,"median":-1.355629,"eighty":-0.476569,"marketCap":92369847},{"date":"2024-10-18","current":-2.988404,"twenty":-10.368251,"median":-1.355629,"eighty":-0.476569,"marketCap":108248941},{"date":"2024-10-25","current":-3.859798,"twenty":-10.296091,"median":-1.355629,"eighty":-0.476569,"marketCap":139813480},{"date":"2024-11-01","current":-3.465532,"twenty":-10.075461,"median":-1.355629,"eighty":-0.476569,"marketCap":125531978},{"date":"2024-11-08","current":-17.384208,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":138343527},{"date":"2024-11-15","current":-16.317377,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":129853685},{"date":"2024-11-22","current":-13.319503,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":105996602},{"date":"2024-11-29","current":-12.556886,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":99927695},{"date":"2024-12-06","current":-13.3458,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":106205874},{"date":"2024-12-13","current":-12.136131,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":96579332},{"date":"2024-12-20","current":-11.715377,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":93230970},{"date":"2024-12-27","current":-10.95276,"twenty":-10.010089,"median":-1.355629,"eighty":-0.476569,"marketCap":87162062},{"date":"2025-01-03","current":-11.031651,"twenty":-9.993746,"median":-1.355629,"eighty":-0.476569,"marketCap":87789880},{"date":"2025-01-10","current":-9.204,"twenty":-9.839122,"median":-1.354318,"eighty":-0.476539,"marketCap":73245431},{"date":"2025-01-17","current":-8.875285,"twenty":-9.760328,"median":-1.354318,"eighty":-0.476539,"marketCap":70629522},{"date":"2025-01-24","current":-9.914023,"twenty":-9.674372,"median":-1.354318,"eighty":-0.476539,"marketCap":78895792},{"date":"2025-01-31","current":-11.071097,"twenty":-9.637166,"median":-1.354318,"eighty":-0.476539,"marketCap":88103789},{"date":"2025-02-07","current":-10.755531,"twenty":-9.637166,"median":-1.354318,"eighty":-0.476539,"marketCap":85592517},{"date":"2025-02-14","current":-9.6642,"twenty":-9.637166,"median":-1.354318,"eighty":-0.476539,"marketCap":76907702},{"date":"2025-02-21","current":-11.097394,"twenty":-9.51462,"median":-1.354318,"eighty":-0.476539,"marketCap":88313062},{"date":"2025-02-28","current":-9.611606,"twenty":-9.475431,"median":-1.354318,"eighty":-0.476539,"marketCap":76489157},{"date":"2025-03-07","current":-10.203291,"twenty":-9.397226,"median":-1.353008,"eighty":-0.476509,"marketCap":81197792},{"date":"2025-03-14","current":-9.716794,"twenty":-9.397226,"median":-1.353008,"eighty":-0.476509,"marketCap":77326247},{"date":"2025-03-21","current":-2.327052,"twenty":-9.356369,"median":-1.353008,"eighty":-0.476509,"marketCap":81747014},{"date":"2025-03-28","current":-2.570086,"twenty":-9.295082,"median":-1.353008,"eighty":-0.476509,"marketCap":90284561},{"date":"2025-04-04","current":-1.761998,"twenty":-9.204,"median":-1.353008,"eighty":-0.476509,"marketCap":61897217},{"date":"2025-04-11","current":-1.488584,"twenty":-9.172579,"median":-1.354318,"eighty":-0.476539,"marketCap":52292476},{"date":"2025-04-17","current":-1.339726,"twenty":-9.072514,"median":-1.353008,"eighty":-0.476539,"marketCap":47063228},{"date":"2025-04-25","current":-1.452129,"twenty":-8.941178,"median":-1.344077,"eighty":-0.476509,"marketCap":51011844},{"date":"2025-05-02","current":-1.531115,"twenty":-8.866079,"median":-1.344077,"eighty":-0.476509,"marketCap":53786547},{"date":"2025-05-09","current":-1.233398,"twenty":-8.809543,"median":-1.339726,"eighty":-0.476509,"marketCap":43328052},{"date":"2025-05-16","current":0.57985,"twenty":-8.783753,"median":-1.321498,"eighty":-0.471829,"marketCap":42335994},{"date":"2025-05-23","current":0.57985,"twenty":-8.7243,"median":-1.290493,"eighty":-0.465201,"marketCap":42335994},{"date":"2025-05-30","current":0.551673,"twenty":-8.654199,"median":-1.281562,"eighty":-0.453231,"marketCap":40278746},{"date":"2025-06-06","current":0.642135,"twenty":-8.602377,"median":-1.252932,"eighty":-0.447022,"marketCap":46883594},{"date":"2025-06-13","current":0.7237,"twenty":-8.580076,"median":-1.245839,"eighty":-0.442908,"marketCap":52838785},{"date":"2025-06-20","current":0.705904,"twenty":-8.498361,"median":-1.236205,"eighty":-0.434561,"marketCap":51539471},{"date":"2025-06-27","current":0.705904,"twenty":-8.373034,"median":-1.227247,"eighty":-0.412935,"marketCap":51539471},{"date":"2025-07-03","current":0.735564,"twenty":-8.260755,"median":-1.199985,"eighty":-0.396513,"marketCap":53704995},{"date":"2025-07-11","current":0.726666,"twenty":-8.038535,"median":-1.16281,"eighty":-0.384301,"marketCap":53055338},{"date":"2025-07-18","current":0.839373,"twenty":-7.755557,"median":-1.151347,"eighty":-0.372146,"marketCap":61284329},{"date":"2025-07-25","current":0.983224,"twenty":-7.608129,"median":-1.137033,"eighty":-0.349659,"marketCap":71787120},{"date":"2025-08-01","current":1.170081,"twenty":-7.413049,"median":-1.10957,"eighty":-0.312271,"marketCap":85429921},{"date":"2025-08-08","current":-2.37628,"twenty":-6.775787,"median":-1.094689,"eighty":-0.302346,"marketCap":109822172},{"date":"2025-08-15","current":-2.547031,"twenty":-4.985761,"median":-1.094689,"eighty":-0.302346,"marketCap":117713586},{"date":"2025-08-22","current":-2.666556,"twenty":-4.936293,"median":-1.094689,"eighty":-0.302346,"marketCap":123237575},{"date":"2025-08-29","current":-2.658019,"twenty":-4.88186,"median":-1.094689,"eighty":-0.302346,"marketCap":122843005},{"date":"2025-09-05","current":-2.891378,"twenty":-4.649605,"median":-1.090896,"eighty":-0.302117,"marketCap":133627936},{"date":"2025-09-12","current":-3.096279,"twenty":-4.558411,"median":-1.094689,"eighty":-0.302346,"marketCap":143097633},{"date":"2025-09-19","current":-3.380864,"twenty":-4.5302,"median":-1.094689,"eighty":-0.302346,"marketCap":156249989},{"date":"2025-09-26","current":-3.286951,"twenty":-4.459441,"median":-1.094689,"eighty":-0.302346,"marketCap":151909711},{"date":"2025-10-03","current":-3.699598,"twenty":-4.338399,"median":-1.094689,"eighty":-0.302346,"marketCap":170980628},{"date":"2025-10-10","current":-4.26023,"twenty":-4.228622,"median":-1.094689,"eighty":-0.302346,"marketCap":196890769},{"date":"2025-10-17","current":-3.984183,"twenty":-4.057774,"median":-1.094689,"eighty":-0.302346,"marketCap":184132984},{"date":"2025-10-24","current":-5.099754,"twenty":-4.057774,"median":-1.094689,"eighty":-0.302346,"marketCap":235690219},{"date":"2025-10-31","current":-5.132481,"twenty":-4.057774,"median":-1.094689,"eighty":-0.302346,"marketCap":237202740},{"date":"2025-11-07","current":-2.030571,"twenty":-4.045993,"median":-1.094689,"eighty":-0.302346,"marketCap":202809329},{"date":"2025-11-14","current":-2.674396,"twenty":-3.984183,"median":-1.094689,"eighty":-0.302346,"marketCap":267113348},{"date":"2025-11-21","current":-3.220895,"twenty":-3.970101,"median":-1.094689,"eighty":-0.302346,"marketCap":321696592},{"date":"2025-11-28","current":-3.449663,"twenty":-3.916538,"median":-1.094689,"eighty":-0.302346,"marketCap":344545392},{"date":"2025-12-05","current":-3.259023,"twenty":-3.873165,"median":-1.094689,"eighty":-0.302346,"marketCap":325504725},{"date":"2025-12-12","current":-3.542259,"twenty":-3.831628,"median":-1.094689,"eighty":-0.302346,"marketCap":353793715},{"date":"2025-12-19","current":-3.433322,"twenty":-3.802783,"median":-1.094689,"eighty":-0.302346,"marketCap":342913334},{"date":"2025-12-26","current":-3.433322,"twenty":-3.771372,"median":-1.094689,"eighty":-0.302346,"marketCap":342913334},{"date":"2026-01-02","current":-3.297151,"twenty":-3.759216,"median":-1.094689,"eighty":-0.302346,"marketCap":329312858},{"date":"2026-01-09","current":-3.106512,"twenty":-3.705978,"median":-1.094689,"eighty":-0.302346,"marketCap":310272192},{"date":"2026-01-16","current":-2.898932,"twenty":-3.680134,"median":-1.094689,"eighty":-0.302346,"marketCap":289539519},{"date":"2026-01-21","current":-2.743235,"twenty":-3.659794,"median":-1.094689,"eighty":-0.302346,"marketCap":273988803}],"updateTime":1769133115475},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602900316","title":"Avalo Therapeutics Files $750 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2602900316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602900316?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:54","pubTimestamp":1767912852,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics  filed a registration statement late Thursday for the sale of $750 million of securities from time to time.The securities cover common and preferred stocks, debt securities, warrants, and units.Net proceeds will be used for general corporate purposes, according to the filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVTX","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2602318914","title":"BRIEF-Avalo Therapeutics Files For Mixed Shelf Of Up To $750 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318914","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318914?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:10","pubTimestamp":1767906651,"startTime":"0","endTime":"0","summary":"BRIEF-Avalo Therapeutics Files For Mixed Shelf Of Up To $750 Million - SEC FilingJan 8  - Avalo Therapeutics Inc AVTX.O:AVALO THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $750 MILLION - SEC FILINGSource text: [ID:n0001104659-26-002118]Further company coverage: AVTX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y90GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"2602318733","title":"Avalo Therapeutics files $750M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2602318733","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602318733?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:05","pubTimestamp":1767906335,"startTime":"0","endTime":"0","summary":"16:03 EST Avalo Therapeutics (AVTX) files $750M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalo-therapeutics-files-750m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalo-therapeutics-files-750m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","AVTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2602131835","title":"Avalo Therapeutics Inc Files for Mixed Shelf of up to $750 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602131835","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602131835?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:02","pubTimestamp":1767906145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y90GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"2592927648","title":"U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar","url":"https://stock-news.laohu8.com/highlight/detail?id=2592927648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592927648?lang=en_us&edition=fundamental","pubTime":"2025-12-18 14:42","pubTimestamp":1766040152,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Autozone, Coursera, LennarDec 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autozone, Courser","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nL4N3XO0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOW","SG9999001176.USD","ALSN","HOUS","ACAD","DG","BK4147","BTSG","SGXZ57979304.SGD","ALB","AJG","CF","CLW","AMAT","CL","LU0345769631.USD","BK4090","DD","AAL","CMI","COUR","AMRZ","BK4107","APD","BBNX","LU1989763690.USD","CRL","ARDT","IE00B7SZLL34.SGD","BRO","AVTX","DAL","LU0234570918.USD","ACHC","CGNX","BAC","BIIB","ACM","AZO","CTVA","AXTA","BK4548","BCAX","CE","ALL","ASH","CPT","CBT","BSX","CLYM"],"gpt_icon":0},{"id":"2588032991","title":"Avalo Therapeutics Unveils Pipeline Progress Highlighting Lead IL-1β Antibody for Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2588032991","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588032991?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:08","pubTimestamp":1764673713,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics Inc. presented updates on its pipeline of novel IL-1β therapies for immune-mediated inflammatory diseases, highlighting its lead compound AVTX-009, an anti-IL-1β monoclonal antibody. AVTX-009 is positioned as a potential best-in-class therapy for hidradenitis suppurativa , addressing unmet needs in patients with incomplete or lost response to current treatments. The company noted that AVTX-009 exhibits 15 times higher affinity and a longer half-life compared to lutikizumab, which may translate to higher efficacy and less frequent dosing. Enrollment for the Phase 2 LOTUS trial in HS is complete, with topline data expected in the second quarter of 2026. The HS market is projected to grow significantly, with additional indications for AVTX-009 under consideration. Avalo stated it has sufficient cash runway into 2028. You can access the full presentation through the link below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL7TL2xg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTX","BK4139"],"gpt_icon":0},{"id":"2581868717","title":"Will Avalo Therapeutics (NASDAQ:AVTX) Spend Its Cash Wisely?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581868717","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581868717?lang=en_us&edition=fundamental","pubTime":"2025-11-08 21:21","pubTimestamp":1762608092,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avtx/avalo-therapeutics/news/will-avalo-therapeutics-nasdaqavtx-spend-its-cash-wisely","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avtx/avalo-therapeutics/news/will-avalo-therapeutics-nasdaqavtx-spend-its-cash-wisely","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","USAW.SI","MNQmain","TQQQ","SQQQ",".IXIC","USJW.SI","PSQ","NVIW.SI","QID","TSYW.SI","AVTX","NQmain","QLD"],"gpt_icon":1},{"id":"2581067246","title":"Avalo Q3 net loss misses estimates, LOTUS trial enrollment complete","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581067246?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:18","pubTimestamp":1762431500,"startTime":"0","endTime":"0","summary":"Avalo Q3 net loss misses estimates, LOTUS trial enrollment completeOverviewAvalo Therapeutics Q3 net loss misses analyst expectationsOperating expenses rose due to Phase 2 LOTUS trial costsCompleted e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI0LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"2581062491","title":"Avalo Therapeutics reports third quarter revenue of zero dollars","url":"https://stock-news.laohu8.com/highlight/detail?id=2581062491","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581062491?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:02","pubTimestamp":1762430566,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics Inc. reported cash, cash equivalents, and short-term investments of $111.6 million as of September 30, 2025. Net cash used in operating activities was $37.2 million for the nine months ended September 30, 2025. The company expects its current cash resources to fund operations into 2028. Product revenue for the third quarter and nine months ended September 30, 2025, was zero, compared to $0.2 million for the same periods in 2024. Recent business developments include the completion of enrollment in the Phase 2 LOTUS trial of AVTX-009 for hidradenitis suppurativa, with topline data expected in mid-2026, and the appointment of Kevin Lind to the Board of Directors, as well as new leadership in business development and human resources.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL1qnlQg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4112","LU0314104364.USD","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","AVTX","LU2210150020.SGD","NDAQ","BK4588","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2581706720","title":"Avalo Therapeutics: Cash & Short-Term Investments of About $112 Mln as of Sept 30, Expected to Provide Runway Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2581706720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581706720?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA997Z3M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVTX","BK4139"],"gpt_icon":0},{"id":"2581438064","title":"Avalo Therapeutics Q3 Operating Expenses USD 19.198 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581438064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581438064?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX39DC11:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"2581064037","title":"Press Release: Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064037","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581064037?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430400,"startTime":"0","endTime":"0","summary":"-- Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment. -- Expanded leadership team with key appointments in business development. -- Cash and short-term investments of approximately $112 million as of. September 30, 2025 expected to provide runway into 2028. WAYNE, Pa., Nov. 06, 2025  -- Avalo Therapeutics, Inc. , a clinical stage biotechnology company fully dedicated to developing IL-1<BETA>-based treatments for immune-mediated inflammatory diseases, today announced business updates and financial results for the third quarter of 2025.\"Now that enrollment is complete, we're fully focused on completing the LOTUS trial, preparing for the data readout in mid-2026, and progressing our Phase 3 planning,\" said Dr. Garry Neil, Chief Executive Officer. \"This marks an important transition for Avalo as we turn our focus from enrollment to completion of the trial, guided by strong conviction in AVTX-009's high-affinity inhibition of IL-1<BETA> and its potential to deliver m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","AVTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2580118972","title":"Avalo Therapeutics Inc  expected to post a loss of $1.66 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580118972","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580118972?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:19","pubTimestamp":1762179560,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics Inc  expected to post a loss of $1.66 a share - Earnings Preview Avalo Therapeutics Inc AVTX.OQ AVTX.O is expected to  show a fall in quarterly revenue when it reports  results on N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF1A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"2580305297","title":"Avalo Therapeutics to Participate in Piper Sandler Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2580305297","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580305297?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:00","pubTimestamp":1762171256,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics Inc. will participate in a fireside chat at the Guggenheim Second Annual Healthcare Innovation Conference on November 10, 2025. The company, dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, will be represented by its management team at the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2YfyVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","PIPR","BK4588","LU2210150020.SGD","LU2095319765.USD","BK4139","NDAQ","IE00B64PRP62.GBP","AVTX","LU2210149790.SGD","BK4127","IE00B3QW5Z07.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2579901358","title":"Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX) and Anavex Life Sciences (AVXL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579901358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579901358?lang=en_us&edition=fundamental","pubTime":"2025-10-29 21:10","pubTimestamp":1761743407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avalo Therapeutics (AVTX – Research Report) and Anav...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avalo-therapeutics-avtx-and-anavex-life-sciences-avxl-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avalo-therapeutics-avtx-and-anavex-life-sciences-avxl-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVXL","LU0029874061.USD","LABU","BK4581","BK4585","LU0128526141.USD","XBI","HCSG","XLV","BK4139","BK4137","AVTX","BK4588"],"gpt_icon":0},{"id":"2579897410","title":"BRIEF-Avalo Therapeutics Announces Completion Of Enrollment In Phase 2 LOTUS Trial Of AVTX-009 For The Treatment Of Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2579897410","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579897410?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:04","pubTimestamp":1761735878,"startTime":"0","endTime":"0","summary":"BRIEF-Avalo Therapeutics Announces Completion Of Enrollment In Phase 2 LOTUS Trial Of AVTX-009 For The Treatment Of Hidradenitis SuppurativaOct 29 (Reuters) - Avalo Therapeutics Inc AVTX.O:AVALO THERA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA2VDXRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVTX","BK4139"],"gpt_icon":0},{"id":"2579974165","title":"Avalo Therapeutics  - Lotus Trial Enrolls 250 Patients, Topline Data From Trial Is Expected in Mid-2026.","url":"https://stock-news.laohu8.com/highlight/detail?id=2579974165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579974165?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA2VDXRV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVTX"],"gpt_icon":0},{"id":"2579971791","title":"Avalo Therapeutics Announces Completion of Enrollment in Phase 2 Lotus Trial of Avtx-009 for the Treatment of Hidradenitis Suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2579971791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579971791?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA2VDXRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVTX","BK4139"],"gpt_icon":0},{"id":"2576303136","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Wuxi Biologics (Cayman) (OtherWXIBF) and Avalo Therapeutics (AVTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2576303136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576303136?lang=en_us&edition=fundamental","pubTime":"2025-10-17 19:00","pubTimestamp":1760698842,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN – Research Report), Wuxi Biologics (Cayman) (WXIBF – ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-wuxi-biologics-cayman-otherwxibf-and-avalo-therapeutics-avtx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-wuxi-biologics-cayman-otherwxibf-and-avalo-therapeutics-avtx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","LU1571399168.USD","XBI","LU0289739699.SGD","LU1023059063.AUD","LU1983299246.USD","BK4588","HCSG","BK4566","LU2242646821.SGD","AMGN","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2242652126.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4139","BK4585","LU0128526141.USD","LABU","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0320765992.SGD","BK4581","LU0868494617.USD","BK4599","BK4137","LU0122379950.USD","LU0058720904.USD","LU0889565916.HKD","AVTX","IE0002141913.USD","XLV","BK4534","LU2112291526.USD","LU0029874061.USD","BK4533","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2574178447","title":"Avalo Therapeutics Inc publishes presentation on advancing IL1β therapies for hidradenitis suppurativa","url":"https://stock-news.laohu8.com/highlight/detail?id=2574178447","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574178447?lang=en_us&edition=fundamental","pubTime":"2025-10-10 19:26","pubTimestamp":1760095574,"startTime":"0","endTime":"0","summary":"Avalo Therapeutics Inc. provided an update on its pipeline of novel IL-1β therapies for immune-mediated inflammatory diseases, highlighting its lead compound, AVTX-009. The company emphasized AVTX-009's potential in treating hidradenitis suppurativa , a chronic inflammatory skin disease with significant unmet medical need. Data presented showed favorable efficacy in patients who had already failed anti-TNF therapy, as well as strong results in bio-nave populations. The management team, including Chief Executive Officer Garry A. Neil, MD, and Chief Medical Officer Mittie Doyle, MD, outlined progress in clinical development and the company's focus on advancing next-generation IL-1β inhibition. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shoul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL5R9NW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVTX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}